Omalizumab discontinuation in children with severe allergic asthma: An observational real‐life study-Reference-Cited by-同舟云学术

Omalizumab discontinuation in children with severe allergic asthma: An observational real‐life study

Published:2019-01-29 Issue:5 Volume:74 Page:999-1003
ISSN:0105-4538
Container-title:Allergy
language:en
Short-container-title:Allergy

Author:

Deschildre Antoine¹^ORCID,Roussel Juliette¹,Drumez Elodie²,Abou‐Taam Rola³,Rames Cinthia⁴,Le Roux Pascal⁵,Pouessel Guillaume⁶,Scalbert Manuëla⁷,Bonnel Cecile⁸,Mitha Sarah⁹,Boileau Sophie¹⁰,Mordacq Clémence¹,Thumerelle Caroline¹,Labreuche Julien²,Lejeune Stéphanie¹,Marguet Christophe¹¹

Affiliation:

1. Pediatric Pulmonology and Allergy Unit Hôpital Jeanne de Flandre CHU Lille Université Nord de France Lille France

2. Department of Biostatistics EA 2694 ‐ Santé publique: épidémiologie et qualité des soins CHU Lille Univ. Lille Lille France

3. Service de Pneumologie et d'Allergologie Pédiatriques AP‐HP Hôpital Necker‐Enfants Malades Paris France

4. Unité de Pneumologie et d'Allergologie Pédiatriques CHU Amiens France

5. Service de Pédiatrie Centre hospitalier Le Havre France

6. Service de Pédiatrie Centre hospitalier Victor Provo Roubaix France

7. Service de Pédiatrie Centre hospitalier Dunkerque France

8. Service de Pédiatrie Centre hospitalier Béthune France

9. Service de Pédiatrie Centre hospitalier Lens France

10. Service de Pédiatrie Centre hospitalier Douai France

11. Pediatric Respiratory Disease and Allergy Unit, Hospital UNIROUEN Inserm EA 2656 Rouen University Hospital Normandie Univ Rouen France

Publisher

Wiley

Subject

Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/all.13678

Reference8 articles.

1. Real-life long-term omalizumab therapy in children with severe allergic asthma

2. Add-on omalizumab in children with severe allergic asthma: a 1-year real life survey

3. Four-year follow-up in children with moderate/severe uncontrolled asthma after withdrawal of a 1-year omalizumab treatment

4. After 6âyears with Xolair; a 3-year withdrawal follow-up

5. Observational study in severe asthmatic patients after discontinuation of omalizumab for good asthma control

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asthma Inception: Epidemiologic Risk Factors and Natural History Across the Life Course;American Journal of Respiratory and Critical Care Medicine;2024-09-15

2. Type 2 Inflammation and Asthma in Children: A Narrative Review;The Journal of Allergy and Clinical Immunology: In Practice;2024-09

3. Histoire naturelle;Revue des Maladies Respiratoires;2024-08

4. De l’asthme difficile à traiter à l’asthme sévère : palier 5;Revue des Maladies Respiratoires;2024-08

5. Clinical remission after biologic therapy discontinuation in pediatric patients with severe asthma: a case series from a tertiary center;Jornal Brasileiro de Pneumologia;2024-06-17